Does application of moderately concentrated platelet-rich plasma improve clinical and structural outcome after arthroscopic repair of medium-sized to large rotator cuff tear? A randomized controlled trial

この研究はハイインパクトの可能性があります。 OEのAI駆動型ハイインパクト指標は、論文が掲載されたジャーナルと論文自体の科学的内容の両方からのシグナルを統合することで、論文が持つ可能性の高い影響力を推定します。 最先端の自然言語処理を用いて開発されたOEハイインパクトモデルは、ジャーナルのインパクトファクターのみよりも、研究の将来の引用実績をより正確に予測します。 これにより、臨床的に意義のある研究をより早く認識することが可能になり、読者は将来の診療を形成する可能性が最も高い論文に集中することができます。

110 patients with a medium- to large-sized, full-thickness rotator cuff tear, who were scheduled for an arthroscopic single-row repair were randomized to the procedure with or without the use of platelet-rich plasma (PRP). The PRP was prepared institutionally and injected intraoperatively over the repair site. Clinical outcome measures of visual analog scale (VAS) pain, Constant-Murley, University of California-LA, and American Shoulder and Elbow Surgeons (ASES) scores were assessed over a 24-month follow-up. In addition, ultrasonographic evaluation of cuff healing was performed. The PRP group demonstrated significantly better results for VAS pain from 1-6 months, Constant-Murley score from 12-24 months, and UCLA scores from 6-24 months after surgery when compared to the control group. As well, the PRP group demonstrated a significantly lower rate of retear on ultrasound after 24 months when compared to the control group.